Advertisement

Picture EBD Group BioPharm America 2019 Boston September 600x60px
All >

News > Northern Europe

Please find below news about Denmark, Estonia, Finland, Iceland, Ireland, Latvia, Lithuania, Norway, Sweden and the UK as well as about organisations from these countries.

Total search results: 4821 | Ordered by Date (descending)
1 2 3 ... 47 48 49  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Spero Therapeutics, Inc.. (6/13/19). "Press Release: Spero Announces $10 Million Registered Direct Offering of Common Stock. Novo Holdings A/S through Its Novo REPAIR Impact Fund to Invest Up to $10 million". Cambridge, MA. 2019-06-13
GlaxoSmithKline plc. (6/13/19). "Press Release: GSK Joins Forces with the University of California to Advance Genomic Research and Improve Drug Discovery". London & San Francisco, CA. 2019-06-13
Ligand Pharmaceuticals Inc.. (6/12/19). "Press Release: Ligand Subsidiary Vernalis and PhoreMost Limited Announce Drug Discovery Collaboration for Novel Oncology". San Diego, CA & Cambridge. 2019-06-12
Medicines Discovery Catapult, The. (6/12/19). "Press Release: Bringing the Benefits of Cutting-edge Mass Spectrometry Technologies to UK SMEs. Medicines Discovery Catapult and Waters Partner". 2019-06-12
Genmab A/S. (6/11/19). "Press Release: Genmab Signs Agreement with Janssen for Next-Generation CD38 Antibody, HexaBody-CD38". Copenhagen. 2019-06-11
Saga Diagnostics AB. (6/11/19). "Press Release: Saga Raises 40 Million SEK (€3.7 Million) to Advance Ultrasensitive Cancer Liquid Biopsies". Lund & Oslo. 2019-06-11
Sphere Fluidics Ltd.. (6/10/19). "Press Release: Sphere Fluidics Closes a $4.8 million USD (£3.7 million) Funding Round". Cambridge. 2019-06-10
Calliditas Therapeutics AB. (6/10/19). "Press Release: Calliditas Therapeutics and Everest Medicines Enter into an Agreement to Develop and Commercialize Nefecon for IgA Nephropathy in Greater China and Singapore". 2019-06-10
Biotage AB. (6/4/19). "Press Release: Strategic Collaboration between Biotage and Yingsheng on the Chinese Market for Clinical Mass Spectrometry Applications". Uppsala. 2019-06-04
Bluebird Bio, Inc.. (6/3/19). "Press Release: Bluebird Bio Announces EU Conditional Marketing Authorization for Zynteglo (autologous CD34+ cells encoding ßA-T87Q-globin gene) Gene Therapy". Cambridge, MA. 2019-06-03
Kiadis Pharma N.V.. (5/31/19). "Press Release: Kiadis Pharma Raises c.EUR 28 Million in a Private Placement of c.3.7 Million New Shares [Not for US, AU, CA, JP, ZA, et al.]". Amsterdam. 2019-05-31
University of Warwick. (5/31/19). "Press Release: Disruptive 2D Mass Spectrometry Spin-out Secures Seed Investment". 2019-05-31
Huntsworth plc. (5/30/19). "Press Release: Huntsworth plc Appoints Annabelle Sandeman as Its New Global Head of Commercial Strategy". London. 2019-05-30
BRAIN AG. (5/29/19). "Press Release: BRAIN AG Achieves Significant Growth in the First Half of the 2018/19 Financial Year". Zwingenberg. 2019-05-29
Oxford BioMedica plc. (5/28/19). "Press Release: Oxford BioMedica Announces Strategic Investment by Novo Holdings A/S". Oxford. 2019-05-28
Biotage AB. (5/24/19). "Press Release: Tomas Blomquist – New CEO & President of Biotage". Uppsala. 2019-05-24
Satellite Applications Catapult. (5/23/19). "Press Release: Innovative Partnership to Embed the Power of Satellite Technology in Digitally Enabled Care". 2019-05-23
Amgen Inc.. (5/21/19). "Press Release: Amgen Announces a Recommended Public Cash Offer to the Shareholders of Nuevolution [Not for Australia, Canada, Hong Kong, Japan, New Zealand or South Africa, et al.]". Thousand Oaks, CA. 2019-05-21
LifeArc. (5/20/19). "Press Release: LifeArc Monetises Keytruda Royalty Interests to Fund further Research and Investment". 2019-05-20
Rinri Therapeutics Ltd.. (5/20/19). "Press Release: Rinri Therapeutics Secures £1.4 Million Seed Funding to Advance Its Novel Regenerative Cell Therapy to Treat Sensorineural Hearing Loss". Sheffield. 2019-05-20
Storm Therapeutics Ltd.. (5/20/19). "Press Release: Storm Therapeutics Extends Series A to GBP 30M (USD 38.43M) with Wew Investor, Seroba Life Sciences". Cambridge. 2019-05-20
Owlstone Medical Ltd.. (5/20/19). "Press Release: Owlstone Medical Enters into a Strategic Collaboration with Actelion to Develop a Breath-Based Test to Help Facilitate Early Detection of Pulmonary Hypertension". Cambridge. 2019-05-20
King’s College London. (5/20/19). "Press Release: Quell Therapeutics Ltd Founded for Emerging Area of Cell Therapy". 2019-05-20
Illumina, Inc.. (5/15/19). "Press Release: Illumina Files Patent Infringement Suit against BGI in Denmark". San Diego, CA. 2019-05-15
Symphogen A/S. (5/15/19). "Press Release: Symphogen Announces New Capital Raise and Explores Strategic Options". 2019-05-15
ProBioGen AG. (5/15/19). "Press Release: ProBioGen and Vaccitech Sign License Agreement for ProBioGen’s Technology Platform". Berlin & Oxford. 2019-05-15
MeiraGTx Holdings plc. (5/14/19). "Press Release: MeiraGTx Reports First Quarter 2019 Financial Results and Provides Corporate Update". London & New York, NY. 2019-05-14
MeiraGTx Holdings plc. (5/14/19). "Press Release: MeiraGTx Announces Positive 6-Month Data from Phase 1/2 Trial of Investigational Gene Therapy AAV-RPE65 for RPE65-Deficiency". London & New York, NY. 2019-05-14
SensID GmbH. (5/14/19). "Press Release: SensID Inks Distribution Agreement with TATAA Biocenter for its MDx Reference Standards". Göteborg & Rostock. 2019-05-14
Sekisui Diagnostics, LLC. (5/14/19). "Press Release: Sekisui Diagnostics Invests $1.9 Million in Microbial Biopharma CDMO Business". Lexington, MA. 2019-05-14
Mobidiag Oy. (5/14/19). "Press Release: Investment Plan for Europe – Mobidiag Secures EUR 25 million from EIB". 2019-05-14
F-Star Biotechnology Ltd.. (5/14/19). "Press Release: F-star Expedites Its Transition to a Wholly-owned Portfolio Strategy". Cambridge. 2019-05-14
Philogen S.p.A.. (5/13/19). "Press Release: Philogen Announces €62 Million Financing Round". Siena. 2019-05-13
MeiraGTx Holdings plc. (5/10/19). "Press Release: MeiraGTx Appoints Nicole Seligman to Board of Directors". London & New York, NY. 2019-05-10
Centogene AG. (5/9/19). "Press Release: Centogene Expands Executive Leadership Team". Cambridge, MA & Rostock. 2019-05-09
Immunocore Ltd.. (5/7/19). "Press Release: Immunocore Appoints Dr Mohammed Dar as Head of Clinical Development and Chief Medical Officer". Oxfordshire, Pennsylvania & Maryland. 2019-05-07
H. Lundbeck A/S. (5/6/19). "Press Release: Lundbeck to Acquire Abide Therapeutics, Adding a Unique Discovery Platform and a Lead Compound in an Exploratory Phase IIa Program for Tourette’s". Valby & San Diego, CA. 2019-05-06
Transgene S.A.. (5/2/19). "Press Release: Transgene and AstraZeneca Enter into a Collaboration and Exclusive License Option Agreement for Innovative Invir.IO based Armed Oncolytic Immunotherapies". Strasbourg. 2019-05-02
Mission Therapeutics Ltd.. (5/1/19). "Press Release: Dr. James Summers Appointed to Mission Therapeutics’ Board of Directors". Cambridge. 2019-05-01
Congenica Ltd.. (4/30/19). "Press Release: Congenica Raises Additional £13.25M ($17.1M) to Reach Total of £23.3M ($30.1M) for Series B Funding Round". Cambridge. 2019-04-30
Merck KGaA. (4/26/19). "Press Release: Merck Presents Plans for Future Growth to Shareholders. 24th Annual General Meeting in Frankfurt am Main". Frankfurt a. M.. 2019-04-26
MeiraGTx Holdings plc. (4/25/19). "Press Release: MeiraGTx Announces Upcoming Presentation on Achromatopsia Gene Therapy Candidate AAV-CNGA3 at ARVO 2019". London & New York, NY. 2019-04-25
Merck KGaA. (4/24/19). "Press Release: Merck Introduces New Greener Solvent, Cyrene". Darmstadt. 2019-04-24
ERS Genomics Ltd.. (4/23/19). "Press Release: US Patent Office Grants Charpentier/Doudna Key CRISPR Patent". Dublin. 2019-04-23
PureTech Health plc. (4/17/19). "Press Release: PureTech Health Announces Collaboration with Boehringer Ingelheim to Advance Immuno-oncology Product Candidates Using Its Lymphatic Targeting Platform". Boston, MA. 2019-04-17
[iito] Business Intelligence. (April 2019). "Special Feature: [iito] Relaunches Life-Sciences-UK.com & Life-Sciences-France.com". Bremen. 2019-04-17
Inivata Ltd.. (4/16/19). "Press Release: Inivata, Thermo Fisher Scientific, and Genomics England Successfully Complete First Phase of Study Assessing Plasma Samples and Potential of Liquid Biopsy". 2019-04-16
Biotechpharma UAB. (4/16/19). "Press Release: Biotechpharma to Expand Process Development and GMP Manufacturing Capacity to 5,000L". Vilnius. 2019-04-16
Gilead Sciences, Inc.. (4/12/19). "Press Release: Gilead Sciences and Novo Nordisk Announce Intent to Initiate a Clinical Collaboration in NASH". Foster City & Bagsvaerd. 2019-04-12
BioStrata Ltd.. (4/11/19). "Press Release: BioStrata Launches Targeted News Distribution Service for Life Science and Healthcare Companies". Cambridge. 2019-04-11
Igem Therapeutics Ltd.. (4/9/19). "Press Release: Igem Therapeutics Appoints Dr David Chiswell as a Non-Executive Chairman". London. 2019-04-09
Probiodrug AG. (4/9/19). "Press Release: Probiodrug Raises EUR 8.2 Million from Investors in Successful Private Placement of New Shares [NOT FOR PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA]". Halle (Saale). 2019-04-09
Kymab Ltd.. (4/8/19). "Press Release: Kymab Appoints Simon Sturge as Chief Executive Officer". Cambridge. 2019-04-08
Metrion Biosciences Ltd.. (4/8/19). "Press Release: Metrion Biosciences Appoints Dr Andrew Southan as Chief Executive Officer". Cambridge. 2019-04-08
Calliditas Therapeutics AB. (4/5/19). "Press Release: Elmar Schnee and Diane Parks Proposed as New Board Members of Calliditas Therapeutics". Stockholm. 2019-04-05
Crescendo Biologics Ltd.. (4/4/19). "Press Release: Theodora Harold to Be Appointed New CEO at Crescendo Biologics". Cambridge. 2019-04-04
Gesynta Pharma AB. (4/4/19). "Press Release: Gesynta Pharma Secures 6 MEUR for Development Programs in Financing Round Led by Industrifonden". Solna. 2019-04-04
ERS Genomics Ltd.. (4/3/19). "Press Release: European Patent Office Grants 3rd Charpentier/Doudna Patent Covering Uses of CRISPR/cas9 in Human and Animal Cells". Dublin. 2019-04-03
Exscientia Ltd.. (4/3/19). "Press Release: Exscientia Achieves Molecule Discovery Milestone as Part of GSK Collaboration". Oxford. 2019-04-03
Lonza Group AG. (4/2/19). "Press Release: Lonza and Chr. Hansen in Joint Venture to Accelerate Momentum in Microbiome". Copenhagen & Basel. 2019-04-02
Centogene AG. (4/2/19). "Press Release: Centogene Announces the Appointment of Dr. Flemming Ornskov to the Supervisory Board as Non-Executive Chairman". Rostock & Berlin. 2019-04-02
Cell Mogrify Ltd.. (4/1/19). "Press Release: Mogrify Subsidiary Chondrogenix Secures Funding from SBRI Healthcare to Advance Regenerative Cartilage Therapy to the Clinic". Cambridge. 2019-04-01
Congenica Ltd.. (4/1/19). "Press Release: Congenica Announces On-Premise Deployment Option for its Sapientia Platform". Cambridge. 2019-04-01
Cambridge Innovation Capital plc. (4/1/19). "Press Release: Cambridge Innovation Capital Completes £150 Million New Capital Raise". 2019-04-01
Surface Oncology Inc.. (4/1/19). "Press Release: Surface Oncology Announces Appointment of Wendy Dwyer as Chief Business Officer". Cambridge, MA. 2019-04-01
Mologic Ltd.. (4/1/19). "Press Release: Mologic Expands US and UK Operations. Strengthens Team as Part of Continued International Expansion – Bolsters US Presence with the Opening of Subsidiary in Boston, MA". Bedfordshire. 2019-04-01
Metrion Biosciences Ltd.. (4/1/19). "Press Release: Metrion Biosciences Closes Funding Round. Includes investment from o2h Ventures Therapeutics Fund". Cambridge. 2019-04-01
Illumina, Inc.. (3/29/19). "Press Release: Illumina Files Patent Infringement Suit against BGI in Germany". San Diego, CA. 2019-03-29
Inivata Ltd.. (3/28/19). "Press Release: Inivata Completes $52.6m (£39.8m) Series B Funding Round". Research Triangle Park, NC & Cambridge. 2019-03-28
ArcherDX, Inc.. (3/28/19). "Press Release: ArcherDX Announces Collaboration with University College London to Investigate the Novel Use of Cell-Free Tumor DNA to Detect Disease Recurrence in Lung Cancer Patients". Boulder, CO. 2019-03-28
Cellnovo. (3/28/19). "Press Release: Cellnovo Stops Manufacturing and Commercial Operations. Administrators Appointed at UK Subsidiary Have Actioned a Restructuring Plan to Focus on Identifying Strategic Partners and Investors". Paris. 2019-03-28
Orchard Therapeutics Ltd.. (3/27/19). "Press Release: Orchard Therapeutics Presents New Registrational Data Demonstrating Sustained Clinical Benefit of OTL-200 for the Treatment of MLD". Boston, MA & London. 2019-03-27
Sphere Fluidics Ltd.. (3/26/19). "Press Release: Sphere Fluidics Hires 10 New UK and US Staff in Its Plan to Scale Internationally". Cambridge. 2019-03-26
Enamine Ltd.. (3/26/19). "Press Release: Enamine Extends Multi-year Drug Discovery Collaboration with Lundbeck". Kiev. 2019-03-26
MeiraGTx Holdings plc. (3/26/19). "Press Release: MeiraGTx Reports Full Year 2018 Financial Results". London & New York, NY. 2019-03-26
Evaluate Ltd.. (3/26/19). "Press Release: Evaluate Ltd. Appoints Deborah Kobewka as Chief Executive Officer". London, Boston, MA & Tokyo. 2019-03-26
F-Star Biotechnology Ltd.. (3/25/19). "Press Release: F-star Presents New Data on its Tetravalent Bispecific Antibodies at the AACR 2019 Annual Meeting". Cambridge. 2019-03-25
Aimmune Therapeutics, Inc.. (3/25/19). "Press Release: European Phase 3 Trial of Aimmune Therapeutics’ AR101 Meets Primary Endpoint. Company Intends to Submit European MAA in Mid-2019". Brisbane, CA. 2019-03-25
Verona Pharma plc. (3/21/19). "Press Release: Dr. Martin Edwards Joins Verona Pharma as Non-Executive Director". London. 2019-03-21
Cambridge Cancer Genomics Ltd.. (3/21/19). "Press Release: Genomics England and Cambridge Cancer Genomics (CCG.ai) Announce Immunotherapy Partnership". Cambridge. 2019-03-21
Orchard Therapeutics Ltd.. (3/21/19). "Press Release: Orchard Therapeutics Reports 2018 Financial Results and Reviews Recent Business Highlights". Boston, MA & London. 2019-03-21
Exscientia Ltd.. (3/21/19). "Press Release: Celgene and Exscientia Enter 3-year AI Drug Discovery Collaboration Focused on Accelerating Drug Discovery in Oncology and Autoimmunity". Oxford. 2019-03-21
NeoPhore Ltd.. (3/20/19). "Press Release: NeoPhore Appoints Dr John Haurum as Non-Executive Director. Former F-star CEO Joins the Board of Directors". 2019-03-20
Oncimmune Holdings plc. (3/19/19). "Press Release: Oncimmune Announces the Acquisition of Protagen Diagnostics AG, a Leader in Personalised Immuno-Profiling". Cambridge, MA. 2019-03-19
Cell Mogrify Ltd.. (3/18/19). "Press Release: Mogrify Awarded $555,000 USD (£420,000 GBP) Innovate UK Funding to Accelerate Regenerative Cell Therapies". Cambridge. 2019-03-18
Orchard Therapeutics Ltd.. (3/18/19). "Press Release: Orchard Therapeutics Strengthens Global Manufacturing and Supply Chain Leadership with Appointment of Ran Zheng as Chief Technical Officer". Boston, MA & London. 2019-03-18
Celyad S.A.. (3/18/19). "Press Release: Celyad’s 2019 R&D Day Highlights shRNA Platform and Pipeline of Next-generation NKG2D-based and Off-the-Shelf Non-gene Edited CAR-T Candidates". Mont-Saint-Guibert. 2019-03-18
AstraZeneca plc. (3/14/19). "Press Release: AstraZeneca Showcases Next-generation Oncology Pipeline Addressing Unmet Patient Needs at AACR Annual Meeting". 2019-03-14
Oxford BioMedica plc. (3/14/19). "Press Release: Oxford Biomedica plc Preliminary Results for the Year Ended 31 December 2018". Oxford. 2019-03-14
MolMed S.p.A.. (3/13/19). "Press Release: Partnership in the Field of Rare Genetic Diseases with Rocket Pharma Extended to Three New Therapeutic Indications". Milan. 2019-03-13
Biogen Inc.. (3/12/19). "Press Release: Biogen Enters Into an Agreement to Sell Its Large-Scale Biologics Manufacturing Site in Hillerød, Denmark to Fujifilm". Cambridge. 2019-03-12
ERS Genomics Ltd.. (3/12/19). "Press Release: ERS Genomics Provides Comment on Issuance of University of California CRISPR/Cas9 Patent including Uses of CRISPR »in a Cell«". Dublin. 2019-03-12
Olink Proteomics. (3/12/19). "Press Release: Summa Equity Acquires Olink Proteomics". 2019-03-12
Oxford BioMedica plc. (3/12/19). "Press Release: Oxford Biomedica Announces R&D Collaboration with Microsoft to Improve Gene and Cell Therapy Manufacturing Using the Intelligent Cloud and Machine Learning". Oxford. 2019-03-12
Snipr Biome ApS. (3/11/19). "Press Release: Snipr Biome Raises $50 Million Series A Financing to Advance CRISPR-based Microbiome Drugs to Human Clinical Trials". Copenhagen. 2019-03-11
Seres Therapeutics, Inc.. (3/11/19). "Press Release: Seres Therapeutics Announces Microbiome Immuno-Oncology Focused Collaboration with AstraZeneca". Cambridge, MA. 2019-03-11
Abivax S.A.. (3/11/19). "Press Release: Abivax Presents Impressive New Phase 2a ABX464 Ulcerative Colitis 6-Months Maintenance Study Data in Oral Plenary Session at Annual Congress of European Crohn’s and Colitis Organisation (ECCO)". Paris. 2019-03-11
Modus Therapeutics AB. (3/11/19). "Press Release: Modus Therapeutics Strengthens Management Team with Appointment of Mats Blom, MBA as CFO". Stockholm. 2019-03-11
H. Lundbeck A/S. (3/8/19). "Press Release: Lundbeck Appoints Keld Flintholm Jørgensen as EVP and Chief Business Officer". Valby. 2019-03-08
MorphoSys AG. (3/7/19). "Press Release: MorphoSys Provides Updates on L-MIND and B-MIND Clinical Trials of MOR208 in Relapsed/Refractory DLBCL". Planegg. 2019-03-07
1 2 3 ... 47 48 49  next pagenext page



Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica 600x60px

» top